{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:26:13Z","timestamp":1787509573437,"version":"build-2736575974"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cell-free DNA profiling using patient blood is emerging as a non-invasive complementary technique for cancer genomic characterization. Since these liquid biopsies will soon be integrated into clinical trial protocols for pediatric cancer treatment, clinicians should be informed about potential applications and advantages but also weaknesses and potential pitfalls. Small retrospective studies comparing genetic alterations detected in liquid biopsies with tumor biopsies for pediatric solid tumor types are encouraging. Molecular detection of tumor markers in cell-free DNA could be used for earlier therapy response monitoring and residual disease detection as well as enabling detection of pathognomonic and therapeutically relevant genomic alterations.<\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : Existing analyses of liquid biopsies from children with solid tumors increasingly suggest a potential relevance for molecular diagnostics, prognostic assessment, and therapeutic decision-making. Gaps remain in the types of tumors studied and value of detection methods applied. Here we review the current stand of liquid biopsy studies for pediatric solid tumors with a dedicated focus on cell-free DNA analysis. There is legitimate hope that integrating fully validated liquid biopsy\u2013based innovations into the standard of care will advance patient monitoring and personalized treatment of children battling solid cancers.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Liquid biopsies are finding their way into routine oncological screening, diagnosis, and disease monitoring in adult cancer types fast.<\/jats:italic>\n                              \u2022\n                              <jats:italic>The most widely adopted source for liquid biopsies is blood although other easily accessible body fluids, such as saliva, pleural effusions, urine, or cerebrospinal fluid (CSF) can also serve as sources for liquid biopsies<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Retrospective proof-of-concept studies in small cohorts illustrate that liquid biopsies in pediatric solid tumors yield tremendous potential to be used in diagnostics, for therapy response monitoring and in residual disease detection.<\/jats:italic>\n                              \u2022\n                              <jats:italic>Liquid biopsy diagnostics could tackle some long-standing issues in the pediatric oncology field; they can enable accurate genetic diagnostics in previously unbiopsied tumor types like renal tumors or brain stem tumors leading to better treatment strategies<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-019-03545-y","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T22:03:01Z","timestamp":1578002581000},"page":"191-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review"],"prefix":"10.1007","volume":"179","author":[{"given":"Ruben","family":"Van Paemel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roos","family":"Vlug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katleen","family":"De Preter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Van Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Speleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Laureys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Schleiermacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godelieve A. M.","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Astrahantseff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedwig","family":"Deubzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-1322","authenticated-orcid":false,"given":"Bram","family":"De Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"3545_CR1","doi-asserted-by":"publisher","unstructured":"Allyse M et al (2015) Non-invasive prenatal testing: a review of international implementation and challenges. Int J Women's Health 113. https:\/\/doi.org\/10.2147\/IJWH.S67124","DOI":"10.2147\/IJWH.S67124"},{"key":"3545_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.cell.2017.01.030","volume":"168","author":"AM Aravanis","year":"2017","unstructured":"Aravanis AM, Lee M, Klausner RD (2017) Next-generation sequencing of circulating tumor DNA for early cancer detection. Cell 168:571\u2013574","journal-title":"Cell"},{"key":"3545_CR3","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA, MacConaill L, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116:1919\u20131923","journal-title":"Blood"},{"key":"3545_CR4","doi-asserted-by":"crossref","unstructured":"Barris DM et al (2018) Detection of circulating tumor DNA in patients with osteosarcoma. Oncotarget 9","DOI":"10.18632\/oncotarget.24268"},{"key":"3545_CR5","unstructured":"Berry J et al (2017) Aqueous humor as a surrogate liquid tumor biopsy in retinoblastoma. ISOO 2017, Abstract 0028"},{"issue":"11","key":"3545_CR6","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1158\/1541-7786.MCR-18-0369","volume":"16","author":"Jesse L. Berry","year":"2018","unstructured":"Berry JL et al (2018) Genomic cfDNA analysis of aqueous humor in retinoblastoma predicts eye salvage: the surrogate tumor biopsy for retinoblastoma. Mol Cancer Res. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0369","journal-title":"Molecular Cancer Research"},{"key":"3545_CR7","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6:224ra24","journal-title":"Sci Transl Med"},{"key":"3545_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/0971-9261.54811","volume":"14","author":"S Bhatnagar","year":"2009","unstructured":"Bhatnagar S (2009) Management of Wilms\u2019 tumor: NWTS vs SIOP. J Indian Assoc Pediatr Surg 14:6\u201314","journal-title":"J Indian Assoc Pediatr Surg"},{"key":"3545_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/hon.2437_51","volume":"35","author":"A Bruscaggin","year":"2017","unstructured":"Bruscaggin A et al (2017) Genotyping of classical Hodgkin lymphoma on the liquid biopsy. Hematol Oncol 35:64\u201365","journal-title":"Hematol Oncol"},{"key":"3545_CR10","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1038\/s41467-018-04745-0","volume":"9","author":"P Burnham","year":"2018","unstructured":"Burnham P et al (2018) Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract. Nat Commun 9:2412","journal-title":"Nat Commun"},{"key":"3545_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/asheducation-2010.1.7","volume":"2010","author":"D Campana","year":"2010","unstructured":"Campana D (2010) Minimal residual disease in acute lymphoblastic leukemia. Hematology 2010:7\u201312","journal-title":"Hematology"},{"key":"3545_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, H\u00f6lsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Br\u00fcck W, Hofer S, Brehmer S, Seiz-Rosenhagen M, H\u00e4nggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, M\u00fchleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, M\u00fcller HL, Rutkowski S, von Hoff K, Fr\u00fchwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Bl\u00fcmcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Sch\u00fcller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474","journal-title":"Nature"},{"key":"3545_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12864-016-2727-x","volume":"17","author":"T Chen","year":"2016","unstructured":"Chen T et al (2016) Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types. BMC Genomics 17:394","journal-title":"BMC Genomics"},{"key":"3545_CR14","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1158\/1078-0432.CCR-16-0500","volume":"22","author":"M Chicard","year":"2016","unstructured":"Chicard M, Boyault S, Colmet Daage L, Richer W, Gentien D, Pierron G, Lapouble E, Bellini A, Clement N, Iacono I, Br\u00e9jon S, Carrere M, Reyes C, Hocking T, Bernard V, Peuchmaur M, Corradini N, Faure-Conter C, Coze C, Plantaz D, Defachelles AS, Thebaud E, Gambart M, Millot F, Valteau-Couanet D, Michon J, Puisieux A, Delattre O, Combaret V, Schleiermacher G (2016) Genomic copy number profiling using circulating free tumor DNA highlights heterogeneity in neuroblastoma. Clin Cancer Res 22:5564\u20135573","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3545_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1158\/1078-0432.CCR-17-1586","volume":"24","author":"Mathieu Chicard","year":"2017","unstructured":"Chicard M et al (2017) Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma. Clin Cancer Res 1586. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1586","journal-title":"Clinical Cancer Research"},{"key":"3545_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000440975","volume":"41","author":"A Clementi","year":"2016","unstructured":"Clementi A, Virz\u00ec GM, Brocca A, Pastori S, de Cal M, Marcante S, Granata A, Ronco C (2016) The role of cell-free plasma DNA in critically ill patients with sepsis. Blood Purif 41:34\u201340","journal-title":"Blood Purif"},{"key":"3545_CR17","first-page":"3646","volume":"62","author":"V Combaret","year":"2002","unstructured":"Combaret V et al (2002) Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients. Cancer Res 62:3646\u20133648","journal-title":"Cancer Res"},{"key":"3545_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/cam4.414","volume":"4","author":"V Combaret","year":"2015","unstructured":"Combaret V et al (2015) Detection of tumor ALK status in neuroblastoma patients using peripheral blood. Cancer Med 4:540\u2013550","journal-title":"Cancer Med"},{"key":"3545_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27052","volume":"65","author":"MV Corrias","year":"2018","unstructured":"Corrias MV et al (2018) Event-free survival of infants and toddlers enrolled in the HR-NBL-1\/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis. Pediatr Blood Cancer 65:e27052","journal-title":"Pediatr Blood Cancer"},{"key":"3545_CR20","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1158\/2159-8290.CD-13-1037","volume":"4","author":"BD Crompton","year":"2014","unstructured":"Crompton BD, Stewart C, Taylor-Weiner A, Alexe G, Kurek KC, Calicchio ML, Kiezun A, Carter SL, Shukla SA, Mehta SS, Thorner AR, de Torres C, Lavarino C, Su\u00f1ol M, McKenna A, Sivachenko A, Cibulskis K, Lawrence MS, Stojanov P, Rosenberg M, Ambrogio L, Auclair D, Seepo S, Blumenstiel B, DeFelice M, Imaz-Rosshandler I, Schwarz-Cruz Y Celis A, Rivera MN, Rodriguez-Galindo C, Fleming MD, Golub TR, Getz G, Mora J, Stegmaier K (2014) The genomic landscape of pediatric Ewing sarcoma. Cancer Discov 4:1326\u20131341","journal-title":"Cancer Discov"},{"key":"3545_CR21","doi-asserted-by":"publisher","unstructured":"De Koker A, Van Paemel R, De Wilde B, De Preter K, Callewaert N (2019) A versatile method for circulating cell-free DNA methylome profiling by reduced representation bisulfite sequencing. bioRxiv 663195. https:\/\/doi.org\/10.1101\/663195","DOI":"10.1101\/663195"},{"key":"3545_CR22","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1038\/ncomms9839","volume":"6","author":"L De Mattos-Arruda","year":"2015","unstructured":"De Mattos-Arruda L et al (2015) Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun 6:8839","journal-title":"Nat Commun"},{"key":"3545_CR23","doi-asserted-by":"publisher","first-page":"241ra77","DOI":"10.1126\/scitranslmed.3007803","volume":"6","author":"I De Vlaminck","year":"2014","unstructured":"De Vlaminck I et al (2014) Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med 6:241ra77","journal-title":"Sci Transl Med"},{"key":"3545_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cca.2013.05.022","volume":"424","author":"S El Messaoudi","year":"2013","unstructured":"El Messaoudi S, Rolet F, Mouliere F, Thierry AR (2013) Circulating cell free DNA: Preanalytical considerations. Clin Chim Acta 424:222\u2013230","journal-title":"Clin Chim Acta"},{"key":"3545_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald N, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883\u2013892","journal-title":"N Engl J Med"},{"key":"3545_CR26","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1111\/ajt.13387","volume":"15","author":"EM Gielis","year":"2015","unstructured":"Gielis EM, Ledeganck KJ, de Winter BY, del Favero J, Bosmans JL, Claas FH, Abramowicz D, Eikmans M (2015) Cell-free DNA: an upcoming biomarker in transplantation. Am J Transplant 15:2541\u20132551","journal-title":"Am J Transplant"},{"key":"3545_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrg.2016.49","volume":"17","author":"S Goodwin","year":"2016","unstructured":"Goodwin S, McPherson JD, McCombie WR (2016) Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet 17:333\u2013351","journal-title":"Nat Rev Genet"},{"key":"3545_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature25480","volume":"555","author":"SN Gr\u00f6bner","year":"2018","unstructured":"Gr\u00f6bner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, H\u00fcbschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H, ICGC PedBrain-Seq Project, ICGC MMML-Seq Project, Burkhardt B, Kratz CP, Witt O, van Tilburg C, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Fr\u00fchwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM (2018) The landscape of genomic alterations across childhood cancers. Nature 555:321\u2013327","journal-title":"Nature"},{"key":"3545_CR29","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3892\/or.2013.2286","volume":"29","author":"TB Hartomo","year":"2013","unstructured":"Hartomo TB et al (2013) Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells. Oncol Rep 29:1629\u20131636","journal-title":"Oncol Rep"},{"key":"3545_CR30","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1002\/cncr.30144","volume":"122","author":"M Hayashi","year":"2016","unstructured":"Hayashi M, Chu D, Meyer CF, Llosa NJ, McCarty G, Morris CD, Levin AS, Wolinsky JP, Albert CM, Steppan DA, Park BH, Loeb DM (2016) Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA. Cancer 122:3015\u20133023","journal-title":"Cancer"},{"key":"3545_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-017-0436-6","volume":"5","author":"TY Huang","year":"2017","unstructured":"Huang TY et al (2017) Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun 5:28","journal-title":"Acta Neuropathol Commun"},{"key":"3545_CR32","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373:1541\u20131552","journal-title":"N Engl J Med"},{"issue":"1","key":"3545_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ijc.31620","volume":"144","author":"Irene Jim\u00e9nez","year":"2018","unstructured":"Jim\u00e9nez I et al (2018) Circulating tumor DNA analysis enables molecular characterisation of pediatric renal tumors at diagnosis. Int J Cancer. https:\/\/doi.org\/10.1002\/ijc.31620","journal-title":"International Journal of Cancer"},{"key":"3545_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clim.2014.10.003","volume":"156","author":"BM Jonkman-Berk","year":"2015","unstructured":"Jonkman-Berk BM, van den Berg J, ten Berge I, Bredius RG, Driessen GJ, Dalm VA, van Dissel J, van Deuren M, Ellerbroek PM, van der Flier M, van Hagen P, van Montfrans J, Rutgers A, Sch\u00f6lvinck EH, de Vries E, van Beem R, Kuijpers TW (2015) Primary immunodeficiencies in the Netherlands: National patient data demonstrate the increased risk of malignancy. Clin Immunol 156:154\u2013162","journal-title":"Clin Immunol"},{"key":"3545_CR35","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.clinbiochem.2016.03.012","volume":"49","author":"Q Kang","year":"2016","unstructured":"Kang Q, Henry NL, Paoletti C, Jiang H, Vats P, Chinnaiyan AM, Hayes DF, Merajver SD, Rae JM, Tewari M (2016) Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes. Clin Biochem 49:1354\u20131360","journal-title":"Clin Biochem"},{"key":"3545_CR36","doi-asserted-by":"publisher","unstructured":"Klega K et al (2018) Detection of somatic structural variants enables quantification and characterization of circulating tumor DNA in children with solid tumors. JCO Precis Oncol:1\u201313. https:\/\/doi.org\/10.1200\/PO.17.00285","DOI":"10.1200\/PO.17.00285"},{"key":"3545_CR37","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1158\/1078-0432.CCR-15-3028","volume":"22","author":"M Krumbholz","year":"2016","unstructured":"Krumbholz M et al (2016) Genomic EWSR1 fusion sequence as highly sensitive and dynamic plasma tumor marker in Ewing sarcoma. Clin Cancer Res 22:4356\u20134365","journal-title":"Clin Cancer Res"},{"key":"3545_CR38","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1016\/j.jpedsurg.2015.08.033","volume":"50","author":"S Kurihara","year":"2015","unstructured":"Kurihara S, Ueda Y, Onitake Y, Sueda T, Ohta E, Morihara N, Hirano S, Irisuna F, Hiyama E (2015) Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors. J Pediatr Surg 50:2094\u20132097","journal-title":"J Pediatr Surg"},{"key":"3545_CR39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10689-010-9368-z","volume":"9","author":"CRM Lammens","year":"2010","unstructured":"Lammens CRM et al (2010) Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits. Familial Cancer 9:647\u2013654","journal-title":"Familial Cancer"},{"key":"3545_CR40","first-page":"646","volume":"37","author":"SA Leon","year":"1977","unstructured":"Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646\u2013650","journal-title":"Cancer Res"},{"issue":"49","key":"3545_CR41","doi-asserted-by":"publisher","first-page":"85234","DOI":"10.18632\/oncotarget.19076","volume":"8","author":"Marco Lodrini","year":"2017","unstructured":"Lodrini M et al (2017) Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.19076","journal-title":"Oncotarget"},{"key":"3545_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"3545_CR43","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3109\/10428191003746331","volume":"51","author":"ASC Machado","year":"2010","unstructured":"Machado ASC et al (2010) Circulating cell-free and Epstein\u2013Barr virus DNA in pediatric B-non-Hodgkin lymphomas. Leuk Lymphoma 51:1020\u20131027","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"3545_CR44","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1158\/1078-0432.CCR-17-3800","volume":"24","author":"Francisco Mart\u00ednez-Ricarte","year":"2018","unstructured":"Mart\u00ednez-Ricarte F et al (2018) Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3800","journal-title":"Clinical Cancer Research"},{"key":"3545_CR45","doi-asserted-by":"publisher","first-page":"e0166354","DOI":"10.1371\/journal.pone.0166354","volume":"11","author":"I Medina Diaz","year":"2016","unstructured":"Medina Diaz I et al (2016) Performance of Streck cfDNA blood collection tubes for liquid biopsy testing. PLoS One 11:e0166354","journal-title":"PLoS One"},{"key":"3545_CR46","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-019-0882-3","volume":"565","author":"AM Miller","year":"2019","unstructured":"Miller AM, Shah RH, Pentsova EI, Pourmaleki M, Briggs S, Distefano N, Zheng Y, Skakodub A, Mehta SA, Campos C, Hsieh WY, Selcuklu SD, Ling L, Meng F, Jing X, Samoila A, Bale TA, Tsui DWY, Grommes C, Viale A, Souweidane MM, Tabar V, Brennan CW, Reiner AS, Rosenblum M, Panageas KS, DeAngelis L, Young RJ, Berger MF, Mellinghoff IK (2019) Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature 565:654\u2013658","journal-title":"Nature"},{"key":"3545_CR47","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","volume":"9","author":"J Moss","year":"2018","unstructured":"Moss J et al (2018) Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat Commun 9:5068","journal-title":"Nat Commun"},{"key":"3545_CR48","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","volume":"291","author":"VH Murthy","year":"2004","unstructured":"Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials. JAMA 291:2720","journal-title":"JAMA"},{"key":"3545_CR49","doi-asserted-by":"publisher","first-page":"323","DOI":"10.7150\/jca.6226","volume":"4","author":"L Mussolin","year":"2013","unstructured":"Mussolin L, Burnelli R, Pillon M, Carraro E, Farruggia P, Todesco A, Mascarin M, Rosolen A (2013) Plasma cell-free DNA in paediatric lymphomas. J Cancer 4:323\u2013329","journal-title":"J Cancer"},{"key":"3545_CR50","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/0883073808321768","volume":"23","author":"F Nejat","year":"2008","unstructured":"Nejat F, El Khashab M, Rutka JT (2008) Initial management of childhood brain tumors: neurosurgical considerations. J Child Neurol 23:1136\u20131148","journal-title":"J Child Neurol"},{"key":"3545_CR51","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<552::AID-IJC8>3.0.CO;2-T","volume":"71","author":"M Nishi","year":"1997","unstructured":"Nishi M, Miyake H, Takeda T, Hanai J, Kikuchi Y, Takasugi N (1997) Mass screening for neuroblastoma and mortality in birth cohorts. Int J Cancer 71:552\u2013555","journal-title":"Int J Cancer"},{"key":"3545_CR52","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"27","author":"KW Pajtler","year":"2015","unstructured":"Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, Capper D, Schweizer L, Sieber L, Wittmann A, Huang Z, van Sluis P, Volckmann R, Koster J, Versteeg R, Fults D, Toledano H, Avigad S, Hoffman LM, Donson AM, Foreman N, Hewer E, Zitterbart K, Gilbert M, Armstrong TS, Gupta N, Allen JC, Karajannis MA, Zagzag D, Hasselblatt M, Kulozik AE, Witt O, Collins VP, von Hoff K, Rutkowski S, Pietsch T, Bader G, Yaspo ML, von Deimling A, Lichter P, Taylor MD, Gilbertson R, Ellison DW, Aldape K, Korshunov A, Kool M, Pfister SM (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27:728\u2013743","journal-title":"Cancer Cell"},{"key":"3545_CR53","doi-asserted-by":"crossref","unstructured":"Paret C et al (2017) Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy. Oncotarget 8","DOI":"10.18632\/oncotarget.23174"},{"key":"3545_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2009.01281.x","volume":"77","author":"MLM Poulsen","year":"2010","unstructured":"Poulsen MLM, Budtz-J\u00f8rgensen E, Bisgaard ML (2010) Surveillance in von Hippel-Lindau disease (vHL). Clin Genet 77:49\u201359","journal-title":"Clin Genet"},{"key":"3545_CR55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.7150\/jca.13593","volume":"7","author":"S Primerano","year":"2016","unstructured":"Primerano S, Burnelli R, Carraro E, Pillon M, Elia C, Farruggia P, Sala A, Vinti L, Buffardi S, Basso G, Mascarin M, Mussolin L (2016) Kinetics of circulating plasma cell-free dna in paediatric classical Hodgkin lymphoma. J Cancer 7:364\u2013366","journal-title":"J Cancer"},{"key":"3545_CR56","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ng.2529","volume":"45","author":"TJ Pugh","year":"2013","unstructured":"Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, Ramos AH, Shefler E, Sivachenko A, Sougnez C, Stewart C, Ally A, Birol I, Chiu R, Corbett RD, Hirst M, Jackman SD, Kamoh B, Khodabakshi AH, Krzywinski M, Lo A, Moore RA, Mungall KL, Qian J, Tam A, Thiessen N, Zhao Y, Cole KA, Diamond M, Diskin SJ, Mosse YP, Wood AC, Ji L, Sposto R, Badgett T, London WB, Moyer Y, Gastier-Foster JM, Smith MA, Guidry Auvil JM, Gerhard DS, Hogarty MD, Jones SJ, Lander ES, Gabriel SB, Getz G, Seeger RC, Khan J, Marra MA, Meyerson M, Maris JM (2013) The genetic landscape of high-risk neuroblastoma. Nat Genet 45:279\u2013284","journal-title":"Nat Genet"},{"key":"3545_CR57","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1056\/NEJMoa012277","volume":"346","author":"FH Schilling","year":"2002","unstructured":"Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J (2002) Neuroblastoma screening at one year of age. N Engl J Med 346:1047\u20131053","journal-title":"N Engl J Med"},{"key":"3545_CR58","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/annonc\/mdy544","volume":"30","author":"J Seoane","year":"2019","unstructured":"Seoane J, De Mattos-Arruda L, Le Rhun E, Bardelli A, Weller M (2019) Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases. Ann Oncol 30:211\u2013218","journal-title":"Ann Oncol"},{"key":"3545_CR59","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","volume":"563","author":"SY Shen","year":"2018","unstructured":"Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D, Zuzarte PC, Borgida A, Wang TT, Li T, Kis O, Zhao Z, Spreafico A, Medina TDS, Wang Y, Roulois D, Ettayebi I, Chen Z, Chow S, Murphy T, Arruda A, O'Kane GM, Liu J, Mansour M, McPherson J, O'Brien C, Leighl N, Bedard PL, Fleshner N, Liu G, Minden MD, Gallinger S, Goldenberg A, Pugh TJ, Hoffman MM, Bratman SV, Hung RJ, de Carvalho DD (2018) Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature 563:579\u2013583","journal-title":"Nature"},{"key":"3545_CR60","doi-asserted-by":"publisher","unstructured":"Shukla NN et al (2017) Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with EWSR1 fusion-positive Sarcomas. JCO Precis Oncol:1\u201311. https:\/\/doi.org\/10.1200\/PO.16.00028","DOI":"10.1200\/PO.16.00028"},{"issue":"9","key":"3545_CR61","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","volume":"14","author":"Giulia Siravegna","year":"2017","unstructured":"Siravegna G, Marsoni S, Siena S, Bardelli A (2017) Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. https:\/\/doi.org\/10.1038\/nrclinonc.2017.14","journal-title":"Nature Reviews Clinical Oncology"},{"key":"3545_CR62","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","volume":"164","author":"D Sturm","year":"2016","unstructured":"Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, Reimand J, Mackay A, Carvalho DM, Remke M, Phillips JJ, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero F, \u0141astowska M, Grajkowska W, Scheurlen W, Pietsch T, Hagel C, Gojo J, L\u00f6tsch D, Berger W, Slavc I, Haberler C, Jouvet A, Holm S, Hofer S, Prinz M, Keohane C, Fried I, Mawrin C, Scheie D, Mobley BC, Schniederjan MJ, Santi M, Buccoliero AM, Dahiya S, Kramm CM, von Bueren A, von Hoff K, Rutkowski S, Herold-Mende C, Fr\u00fchwald MC, Milde T, Hasselblatt M, Wesseling P, R\u00f6\u00dfler J, Sch\u00fcller U, Ebinger M, Schittenhelm J, Frank S, Grobholz R, Vajtai I, Hans V, Schneppenheim R, Zitterbart K, Collins VP, Aronica E, Varlet P, Puget S, Dufour C, Grill J, Figarella-Branger D, Wolter M, Schuhmann MU, Shalaby T, Grotzer M, van Meter T, Monoranu CM, Felsberg J, Reifenberger G, Snuderl M, Forrester LA, Koster J, Versteeg R, Volckmann R, van Sluis P, Wolf S, Mikkelsen T, Gajjar A, Aldape K, Moore AS, Taylor MD, Jones C, Jabado N, Karajannis MA, Eils R, Schlesner M, Lichter P, von Deimling A, Pfister SM, Ellison DW, Korshunov A, Kool M (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060\u20131072","journal-title":"Cell"},{"key":"3545_CR63","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1373\/clinchem.2008.117945","volume":"55","author":"J Stutterheim","year":"2009","unstructured":"Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Yalcin B, Dee R, van Noesel M, Berthold F, Versteeg R, Caron HN, van der Schoot C, Tytgat GA (2009) Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers. Clin Chem 55:1316\u20131326","journal-title":"Clin Chem"},{"key":"3545_CR64","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.ejca.2011.02.003","volume":"47","author":"J Stutterheim","year":"2011","unstructured":"Stutterheim J, Zappeij-Kannegieter L, Versteeg R, Caron HN, van der Schoot C, Tytgat GA (2011) The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma. Eur J Cancer 47:1193\u20131202","journal-title":"Eur J Cancer"},{"key":"3545_CR65","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1158\/1078-0432.CCR-17-0574","volume":"23","author":"U Tabori","year":"2017","unstructured":"Tabori U, Hansford JR, Achatz MI, Kratz CP, Plon SE, Frebourg T, Brugi\u00e8res L (2017) Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood. Clin Cancer Res 23:e32\u2013e37","journal-title":"Clin Cancer Res"},{"key":"3545_CR66","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10555-016-9629-x","volume":"35","author":"AR Thierry","year":"2016","unstructured":"Thierry AR, El Messaoudi S, Gahan PB, Anker P, Stroun M (2016) Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev 35:347\u2013376","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"3545_CR67","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/gcc.22648","volume":"57","author":"Hitomi Ueno-Yokohata","year":"2018","unstructured":"Ueno-Yokohata H et al (2018) Preoperative diagnosis of clear cell sarcoma of the kidney by detection of BCOR internal tandem duplication in circulating tumor DNA. Genes Chromosom Cancer. https:\/\/doi.org\/10.1002\/gcc.22648","journal-title":"Genes, Chromosomes and Cancer"},{"issue":"20","key":"3545_CR68","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1158\/1078-0432.CCR-17-0675","volume":"23","author":"Nadine Van Roy","year":"2017","unstructured":"Van Roy N et al (2017) Shallow whole genome sequencing on circulating cell-free DNA allows reliable noninvasive copy-number profiling in neuroblastoma patients. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0675","journal-title":"Clinical Cancer Research"},{"key":"3545_CR69","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jmoldx.2014.09.005","volume":"17","author":"EM Van Wezel","year":"2015","unstructured":"Van Wezel EM et al (2015) Whole-genome sequencing identifies patient-specific DNA minimal residual disease markers in neuroblastoma. J Mol Diagn 17:43\u201352","journal-title":"J Mol Diagn"},{"key":"3545_CR70","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejca.2015.11.007","volume":"54","author":"EM van Wezel","year":"2016","unstructured":"van Wezel EM et al (2016) Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients. Eur J Cancer 54:149\u2013158","journal-title":"Eur J Cancer"},{"key":"3545_CR71","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ejca.2006.08.007","volume":"43","author":"VF Viprey","year":"2007","unstructured":"Viprey VF, Corrias MV, Kagedal B, Oltra S, Swerts K, Vicha A, Ladenstein R, Burchill SA (2007) Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET. Eur J Cancer 43:341\u2013350","journal-title":"Eur J Cancer"},{"key":"3545_CR72","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1200\/JCO.2013.53.3604","volume":"32","author":"VF Viprey","year":"2014","unstructured":"Viprey VF, Gregory WM, Corrias MV, Tchirkov A, Swerts K, Vicha A, Dallorso S, Brock P, Luksch R, Valteau-Couanet D, Papadakis V, Laureys G, Pearson AD, Ladenstein R, Burchill SA (2014) Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1\/SIOPEN study. J Clin Oncol 32:1074\u20131083","journal-title":"J Clin Oncol"},{"issue":"4","key":"3545_CR73","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"Jonathan C. M. Wan","year":"2017","unstructured":"Wan JCM et al (2016) Liquid biopsies come of age: clinical applications of circulating tumour DNA. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/nrc.2017.7","journal-title":"Nature Reviews Cancer"},{"key":"3545_CR74","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/07357900500449546","volume":"24","author":"KD Weaver","year":"2006","unstructured":"Weaver KD, Grossman SA, Herman JG (2006) Methylated tumor-specific DNA as a plasma biomarker in patients with Glioma. Cancer Investig 24:35\u201340","journal-title":"Cancer Investig"},{"key":"3545_CR75","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/jmedgenet-2014-102284","volume":"51","author":"K Wimmer","year":"2014","unstructured":"Wimmer K, Kratz CP, Vasen HF, Caron O, Colas C, Entz-Werle N, Gerdes AM, Goldberg Y, Ilencikova D, Muleris M, Duval A, Lavoine N, Ruiz-Ponte C, Slavc I, Burkhardt B, Brugieres L, EU-Consortium Care for CMMRD (C4CMMRD) (2014) Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium \u2018Care for CMMRD\u2019 (C4CMMRD). J Med Genet 51:355\u2013365","journal-title":"J Med Genet"},{"key":"3545_CR76","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1056\/NEJMoa012387","volume":"346","author":"WG Woods","year":"2002","unstructured":"Woods WG et al (2002) Screening of infants and mortality due to neuroblastoma. N Engl J Med 346:1041\u20131046","journal-title":"N Engl J Med"},{"key":"3545_CR77","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2016.06.009","volume":"65","author":"BC Worst","year":"2016","unstructured":"Worst BC, van Tilburg C, Balasubramanian GP, Fiesel P, Witt R, Freitag A, Boudalil M, Previti C, Wolf S, Schmidt S, Chotewutmontri S, Bewerunge-Hudler M, Schick M, Schlesner M, Hutter B, Taylor L, Borst T, Sutter C, Bartram CR, Milde T, Pfaff E, Kulozik AE, von Stackelberg A, Meisel R, Borkhardt A, Reinhardt D, Klusmann JH, Fleischhack G, Tippelt S, Dirksen U, J\u00fcrgens H, Kramm CM, von Bueren A, Westermann F, Fischer M, Burkhardt B, W\u00f6\u00dfmann W, Nathrath M, Bielack SS, Fr\u00fchwald MC, Fulda S, Klingebiel T, Koscielniak E, Schwab M, Tremmel R, Driever PH, Schulte JH, Brors B, von Deimling A, Lichter P, Eggert A, Capper D, Pfister SM, Jones DT, Witt O (2016) Next-generation personalised medicine for high-risk paediatric cancer patients - the INFORM pilot study. Eur J Cancer 65:91\u2013101","journal-title":"Eur J Cancer"},{"key":"3545_CR78","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00432-015-2054-7","volume":"142","author":"Y Y\u00e1\u00f1ez","year":"2016","unstructured":"Y\u00e1\u00f1ez Y, Herv\u00e1s D, Grau E, Oltra S, P\u00e9rez G, Palanca S, Berm\u00fadez M, M\u00e1rquez C, Ca\u00f1ete A, Castel V (2016) TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients. J Cancer Res Clin Oncol 142:573\u2013580","journal-title":"J Cancer Res Clin Oncol"}],"updated-by":[{"DOI":"10.1007\/s00431-020-03692-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000}}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-019-03545-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-019-03545-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-019-03545-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T19:23:16Z","timestamp":1609528996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-019-03545-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["3545"],"URL":"https:\/\/doi.org\/10.1007\/s00431-019-03545-y","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"29 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2020","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of this article, a reader pointed out that there was a mistake in the phrasing in a paragraph. This could potentially be harmful to children. The authors agree to change the wording. \ufffd\ufffd\ufffdvitreous fluid\ufffd\ufffd\ufffd will be changed to \ufffd\ufffd\ufffdaqueous humor\ufffd\ufffd\ufffd.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}